Pricing Log in Create free account
Saturday 17 October 2026 Export GEHC’s income statement to Excel — free account

GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

GE HealthCare Technologies Inc. (GEHC) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, GE HealthCare Technologies Inc. (GEHC) trades at a P/S ratio of 1.5×. Over the past ten years it has ranged from 0.0× (December 2022) to 2.2× (September 2024); the current reading is higher than 12% of that period. That is below the Medical Devices industry median of 2.3× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 1.8× 0.07%
FY2024 1.8× 1.97%
FY2023 1.8× 28.21%
FY2022 1.4× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period P/S ratio Change
Jun 2026 1.4× (11.87%)
Mar 2026 1.5× (14.68%)
Dec 2025 1.8× 7.21%
Sep 2025 1.7× (0.23%)
14 more quarters

Against its own ten years

Low 0.0× High 2.2×
Ten-year median 1.8×
Current reading's percentile 11

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
SNN Smith & Nephew SNATS, Inc. compare 1.2×
GEHC GE HealthCare Technologies Inc. 1.5×
ZBH Zimmer Biomet Holdings, Inc. compare 2.1×
BSX Boston Scientific Corporation compare 3.1×
STE STERIS plc compare 3.6×
DXCM DexCom, Inc. compare 6.6×
EW Edwards Lifesciences Corporation compare 7.7×
PEN Penumbra, Inc. compare 8.4×
Medical Devices industry median 2.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on GEHC